MedTrace Logo

Fibersol-2 Clinical Trials Related to Appetite

NCT01305291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-02-28

No results posted yet for this study

Summary

Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut.

Conditions

  • Lack of Satiety

Interventions

OTHER

placebo

DIETARY_SUPPLEMENT

digestion-resistant maltodextrin

Sponsors & Collaborators

  • Archer Daniels Midland Co.

    collaborator INDUSTRY

  • Iowa State University

    lead OTHER

Principal Investigators

  • Suzanne Hendrich, PhD · Iowa State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-07-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305291 on ClinicalTrials.gov